{
    "2020-09-18": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Johnson & Johnson stock outperforms competitors on strong trading day",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "outperforms",
                        "strong trading day"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-10",
                "original_text": "First Psychedelic Drug Stock Hits $1 Billion In Debut After Upsized IPO",
                "features": {
                    "keywords": [
                        "Psychedelic Drug Stock",
                        "Upsized IPO",
                        "$1 Billion"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-15",
                "original_text": "EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.?",
                "features": {
                    "keywords": [
                        "COVID-19 vaccines",
                        "generally available",
                        "U.S."
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-05",
                "original_text": "Three-quarters of Americans are worried about the vaccine rush: Pew",
                "features": {
                    "keywords": [
                        "vaccine rush",
                        "worried",
                        "Pew"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-10",
                "original_text": "The First Psychedelic Drug Stock Jumps In Debut After Upsized IPO",
                "features": {
                    "keywords": [
                        "Psychedelic Drug Stock",
                        "Jumps",
                        "Upsized IPO"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-15",
                "original_text": "Dow Jones Extends Losses As Apple Drops; Nasdaq Falls Deeper In The Red",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Losses",
                        "Apple",
                        "Nasdaq",
                        "Falls"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-11-20",
                "original_text": "Price Over Earnings Overview: Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Price Over Earnings",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-25",
                "original_text": "Why Novartisâ€™ Absence From the Covid-19 Vaccine Race Is a Benefit",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Covid-19 Vaccine",
                        "Absence",
                        "Benefit"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-01",
                "original_text": "Moderna CEO downplays vaccine timeline pressure: 'We don't want the first, we want the best'",
                "features": {
                    "keywords": [
                        "Moderna",
                        "CEO",
                        "vaccine timeline",
                        "pressure"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-15",
                "original_text": "These 3 Dividend Aristocrats Will Shield You From Another Market Crash",
                "features": {
                    "keywords": [
                        "Dividend Aristocrats",
                        "Market Crash",
                        "Shield"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-11-25",
                "original_text": "How Much Of Johnson & Johnson (NYSE:JNJ) Do Institutions Own?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Institutions",
                        "Own"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-10",
                "original_text": "3 Coronavirus Vaccines in Phase 3 Clinical Studies: How They Stack Up Against Each Other",
                "features": {
                    "keywords": [
                        "Coronavirus Vaccines",
                        "Phase 3",
                        "Clinical Studies"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-05",
                "original_text": "20/20 GeneSystems Stock: Leveraging AI for More Accurate Cancer Screening",
                "features": {
                    "keywords": [
                        "GeneSystems Stock",
                        "AI",
                        "Cancer Screening"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-20",
                "original_text": "Johnson & Johnson Downplayed Opioid Drugs' Side Effects, New York Unveils Charges",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Opioid Drugs",
                        "Side Effects",
                        "Charges"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}